The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index; 11 of the 25 sources its claims cite were checked for support.
Trends in Sudden Death Among Schizophrenia Inpatients
Open accessAbstract
Background and Objectives: Schizophrenia is associated with a 15–20-year reduction in life expectancy, with cardiovascular disease as the leading cause. Sudden unexpected death is common in this population, often linked to structural heart disease, antipsychotic use, and overlapping cardiometabolic, autonomic, and drug-related factors. This study aimed to determine the incidence and causes of sudden unexpected death among schizophrenia inpatients between 2014 and 2024 and compare these findings with historical data from the same institution. Materials and Methods: We conducted a retrospective cohort study of schizophrenia inpatients admitted from January 2014 to December 2024. Hospital records were reviewed to identify sudden and unexpected deaths, verified by the Forensic Medicine Service Brașov. Sudden death was defined as death in an asymptomatic patient or within one hour of new symptom onset, excluding suicide, homicide, or accidental overdose. In accordance with Romanian legislation, an autopsy was performed in every case. Results: Over the 10-year period, six schizophrenia inpatients (mean age 53.2 ± 17.8 years) died suddenly. All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics. Cardiovascular comorbidity was present in three cases. All patients received antipsychotic treatment within 24 h before death. No deaths occurred within the first 24 h of admission; one occurred within 48 h. Compared with the 1989–2013 cohort, which included 57 sudden deaths, the incidence during 2014–2024 declined substantially (0.27% vs. 0.79%). Conclusions: The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989–2013 cohort, reflecting improved multidisciplinary care, prompt transfer to general hospitals, and wider use of second-generation antipsychotics. Autopsy findings emphasize the continuing importance of cardiovascular disease and airway obstruction as preventable causes of sudden death in this population.
Overview
CoChat Summary
TL;DR
This retrospective single-centre cohort study found that sudden unexpected death among schizophrenia inpatients at a Romanian psychiatric hospital declined from 0.79% in 1989–2013 to 0.27% in 2014–2024. In the 2014–2024 cohort, deaths were still driven by preventable medical causes, especially cardiovascular disease and food bolus airway obstruction.
Key findings
- Among 2,242 schizophrenia inpatients admitted in 2014–2024, 6 died suddenly and unexpectedly; the incidence was 0.27% (95% CI 0.12–0.60%).
- In the 6 recent cases, causes of death were 2 mechanical asphyxia cases from food bolus airway obstruction, 3 cardiovascular deaths (pulmonary thromboembolism, myocardiosclerosis, acute myocardial infarction), and 1 bronchopneumonia.
- Compared with the hospital’s earlier 1989–2013 cohort (57/7,189; 0.79%, 95% CI 0.61–1.03%), the recent cohort had a lower risk of sudden death: RR 0.34 (95% CI 0.15–0.78), with significant tests reported as χ² = 6.34, p = 0.012 and Fisher’s exact p = 0.0068.
- Treatment patterns changed markedly across cohorts: first-generation antipsychotic use fell from 83.4% to 0%, while second-generation antipsychotic use rose from 15.7% to 100% among autopsy-confirmed cases.
Methods
- Retrospective observational cohort study at the Clinical Hospital of Psychiatry and Neurology, Brașov, Romania, covering 2014–2024.
- Included schizophrenia inpatients who died suddenly and unexpectedly during hospitalization; deaths were confirmed by the Forensic Medicine Service, and autopsy was performed in every case by legal medicine pathologists.
- Used descriptive statistics and group comparisons with prior published hospital data (1989–2013) using chi-square/Fisher’s exact tests for categorical variables and Student’s t-test for continuous variables.
Limitations
- The paper states the study is retrospective, so findings are correlational rather than causal.
- The number of events was small in the 2014–2024 cohort, limiting subgroup analyses and yielding relatively wide confidence intervals.
- Comparison with the earlier cohort was limited to autopsy-confirmed cases because detailed demographic data for the full 1989–2013 cohort were unavailable; this is stated in the paper.
- The text also makes evident that the study is single-centre and Romania-specific, which limits generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 15 Not checked · 59 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“prospective registry data show that individuals with schizophrenia are overrepresented among young SCD cases by more than tenfold, with higher burdens of cardiovascular risk factors, unwitnessed arrests, prolonged time-to-discovery, and asystole—all factors associated with poor survival outcomes [10].”
§ Trends in Sudden Death Among Schizophrenia Inpatients > 1. Introduction
What the sources say
- Supportedcites [10] Paratz, 2023, Sudden Cardiac Death in People With Schizophrenia: Higher Risk, Poorer Resuscitation Profiles, and Differing Pathologies, JACC Clin. Electrophysiol. source
The Discussion reports that patients with schizophrenia account for 11% of the young SCD population studied, an 11-fold overrepresentation relative to their prevalence in the general population. The Conclusions specify that these were young SCD patients referred for forensic investigation. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“while one was due to bronchopneumonia.”
§ Trends in Sudden Death Among Schizophrenia Inpatients > 3. Results > 3.1. Causes of Death
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All patients were prescribed second-generation antipsychotics (SGAs) in the 24 h preceding death.”
- Also stated in: § Abstract Background and Objectives: Schizophrenia is associated with a 15–20-year reduction in life expectancy, with cardiovascular disease as the leading cause. Sudden unexpected death is common in this population, often linked to structural heart disease, antipsychotic use, and overlapping cardiometabolic, autonomic, and drug-related factors. This study aimed to determine the incidence and causes of sudden unexpected death among schizophrenia inpatients between 2014 and 2024 and compare these findings with historical data from the same institution. Materials and Methods: We conducted a retrospective cohort study of schizophrenia inpatients admitted from January 2014 to December 2024. Hospital records were reviewed to identify sudden and unexpected deaths, verified by the Forensic Medicine Service Brașov. Sudden death was defined as death in an asymptomatic patient or within one hour of new symptom onset, excluding suicide, homicide, or accidental overdose. In accordance with Romanian legislation, an autopsy was performed in every case. Results: Over the 10-year period, six schizophrenia inpatients (mean age 53.2 ± 17.8 years) died suddenly. All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics. Cardiovascular comorbidity was present in three cases. All patients received antipsychotic treatment within 24 h before death. No deaths occurred within the first 24 h of admission; one occurred within 48 h. Compared with the 1989–2013 cohort, which included 57 sudden deaths, the incidence during 2014–2024 declined substantially (0.27% vs. 0.79%). Conclusions: The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989–2013 cohort, reflecting improved multidisciplinary care, prompt transfer to general hospitals, and wider use of second-generation antipsychotics. Autopsy findings emphasize the continuing importance of cardiovascular disease and airway obstruction as preventable causes of sudden death in this population. · plain
“All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics.”
§ Trends in Sudden Death Among Schizophrenia Inpatients > 3. Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract Background and Objectives: Schizophrenia is associated with a 15–20-year reduction in life expectancy, with cardiovascular disease as the leading cause. Sudden unexpected death is common in this population, often linked to structural heart disease, antipsychotic use, and overlapping cardiometabolic, autonomic, and drug-related factors. This study aimed to determine the incidence and causes of sudden unexpected death among schizophrenia inpatients between 2014 and 2024 and compare these findings with historical data from the same institution. Materials and Methods: We conducted a retrospective cohort study of schizophrenia inpatients admitted from January 2014 to December 2024. Hospital records were reviewed to identify sudden and unexpected deaths, verified by the Forensic Medicine Service Brașov. Sudden death was defined as death in an asymptomatic patient or within one hour of new symptom onset, excluding suicide, homicide, or accidental overdose. In accordance with Romanian legislation, an autopsy was performed in every case. Results: Over the 10-year period, six schizophrenia inpatients (mean age 53.2 ± 17.8 years) died suddenly. All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics. Cardiovascular comorbidity was present in three cases. All patients received antipsychotic treatment within 24 h before death. No deaths occurred within the first 24 h of admission; one occurred within 48 h. Compared with the 1989–2013 cohort, which included 57 sudden deaths, the incidence during 2014–2024 declined substantially (0.27% vs. 0.79%). Conclusions: The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989–2013 cohort, reflecting improved multidisciplinary care, prompt transfer to general hospitals, and wider use of second-generation antipsychotics. Autopsy findings emphasize the continuing importance of cardiovascular disease and airway obstruction as preventable causes of sudden death in this population. · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean age at death was 53.2 years (SD = ±17.8).”
§ Trends in Sudden Death Among Schizophrenia Inpatients > 3. Results
plainn = 6- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Compared with the 1989–2013 cohort, which included 57 sudden deaths, the incidence during 2014–2024 declined substantially (0.27% vs. 0.79%).”
- Also stated in: § Abstract Background and Objectives: Schizophrenia is associated with a 15–20-year reduction in life expectancy, with cardiovascular disease as the leading cause. Sudden unexpected death is common in this population, often linked to structural heart disease, antipsychotic use, and overlapping cardiometabolic, autonomic, and drug-related factors. This study aimed to determine the incidence and causes of sudden unexpected death among schizophrenia inpatients between 2014 and 2024 and compare these findings with historical data from the same institution. Materials and Methods: We conducted a retrospective cohort study of schizophrenia inpatients admitted from January 2014 to December 2024. Hospital records were reviewed to identify sudden and unexpected deaths, verified by the Forensic Medicine Service Brașov. Sudden death was defined as death in an asymptomatic patient or within one hour of new symptom onset, excluding suicide, homicide, or accidental overdose. In accordance with Romanian legislation, an autopsy was performed in every case. Results: Over the 10-year period, six schizophrenia inpatients (mean age 53.2 ± 17.8 years) died suddenly. All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics. Cardiovascular comorbidity was present in three cases. All patients received antipsychotic treatment within 24 h before death. No deaths occurred within the first 24 h of admission; one occurred within 48 h. Compared with the 1989–2013 cohort, which included 57 sudden deaths, the incidence during 2014–2024 declined substantially (0.27% vs. 0.79%). Conclusions: The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989–2013 cohort, reflecting improved multidisciplinary care, prompt transfer to general hospitals, and wider use of second-generation antipsychotics. Autopsy findings emphasize the continuing importance of cardiovascular disease and airway obstruction as preventable causes of sudden death in this population. · plain
“The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989–2013 cohort”
§ Trends in Sudden Death Among Schizophrenia Inpatients > Abstract Background and Objectives: Schizophrenia is associated with a 15–20-year reduction in life expectancy, with cardiovascular disease as the leading cause. Sudden unexpected death is common in this population, often linked to structural heart disease, antipsychotic use, and overlapping cardiometabolic, autonomic, and drug-related factors. This study aimed to determine the incidence and causes of sudden unexpected death among schizophrenia inpatients between 2014 and 2024 and compare these findings with historical data from the same institution. Materials and Methods: We conducted a retrospective cohort study of schizophrenia inpatients admitted from January 2014 to December 2024. Hospital records were reviewed to identify sudden and unexpected deaths, verified by the Forensic Medicine Service Brașov. Sudden death was defined as death in an asymptomatic patient or within one hour of new symptom onset, excluding suicide, homicide, or accidental overdose. In accordance with Romanian legislation, an autopsy was performed in every case. Results: Over the 10-year period, six schizophrenia inpatients (mean age 53.2 ± 17.8 years) died suddenly. All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics. Cardiovascular comorbidity was present in three cases. All patients received antipsychotic treatment within 24 h before death. No deaths occurred within the first 24 h of admission; one occurred within 48 h. Compared with the 1989–2013 cohort, which included 57 sudden deaths, the incidence during 2014–2024 declined substantially (0.27% vs. 0.79%). Conclusions: The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989–2013 cohort, reflecting improved multidisciplinary care, prompt transfer to general hospitals, and wider use of second-generation antipsychotics. Autopsy findings emphasize the continuing importance of cardiovascular disease and airway obstruction as preventable causes of sudden death in this population.
What the sources say
- Not checked — no full text of the sourcecites [6] Ifteni, 2014, Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients, Schizophr. Res. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Abstract Background and Objectives: Schizophrenia is associated with a 15–20-year reduction in life expectancy, with cardiovascular disease as the leading cause. Sudden unexpected death is common in this population, often linked to structural heart disease, antipsychotic use, and overlapping cardiometabolic, autonomic, and drug-related factors. This study aimed to determine the incidence and causes of sudden unexpected death among schizophrenia inpatients between 2014 and 2024 and compare these findings with historical data from the same institution. Materials and Methods: We conducted a retrospective cohort study of schizophrenia inpatients admitted from January 2014 to December 2024. Hospital records were reviewed to identify sudden and unexpected deaths, verified by the Forensic Medicine Service Brașov. Sudden death was defined as death in an asymptomatic patient or within one hour of new symptom onset, excluding suicide, homicide, or accidental overdose. In accordance with Romanian legislation, an autopsy was performed in every case. Results: Over the 10-year period, six schizophrenia inpatients (mean age 53.2 ± 17.8 years) died suddenly. All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics. Cardiovascular comorbidity was present in three cases. All patients received antipsychotic treatment within 24 h before death. No deaths occurred within the first 24 h of admission; one occurred within 48 h. Compared with the 1989–2013 cohort, which included 57 sudden deaths, the incidence during 2014–2024 declined substantially (0.27% vs. 0.79%). Conclusions: The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989–2013 cohort, reflecting improved multidisciplinary care, prompt transfer to general hospitals, and wider use of second-generation antipsychotics. Autopsy findings emphasize the continuing importance of cardiovascular disease and airway obstruction as preventable causes of sudden death in this population. · plain
31 more claims
Create a free account to see all 83 claims and every source verdict.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 37
- The quote only partly states this claim. 1
Citations
Cites
Zipes, D. P., & Wellens, H. J. J. (1998) · Circulation · doi:10.1161/01.cir.98.21.2334 · Cited by 2,744 · cited 1×
“Within this context, sudden unexpected death—classically defined as an unexpected death occurring within approximately one hour of symptom onset [3]—has been a persistent and alarming phenomenon among psychiatric inpatients with schizophrenia.”
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729 · cited 1×
“Schizophrenia is associated with one of the highest risks of premature mortality among psychiatric disorders, with a 15–20 year life expectancy gap [1].”
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194 · cited 1×
“Both first-generation (typical) and second-generation (atypical) antipsychotics can prolong cardiac repolarization (QT interval), increasing the risk of ventricular arrhythmias such as torsades de pointes [27,28].”
Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study
McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · British Journal of Psychiatry · doi:10.1192/03-162 · Cited by 546
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 339 · cited 1×
“This improvement must also be considered in light of the well-documented vulnerability of patients with schizophrenia to cardiovascular disease, metabolic disturbances, and infectious illnesses [56,57].”
Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261 · cited 1×
“Early pharmacoepidemiological evidence from a large U.S. cohort study by Hennessy et al. (2002) [31] showed that patients with treated schizophrenia had a 1.7–3.2-fold higher rate of cardiac arrest and ventricular arrhythmia compared with non-psychiatric controls, with risk particularly elevated at…”
InfluentialAntipsychotics and the Risk of Sudden Cardiac Death
Straus, S. M. J. M., Bleumink, G. S., Dieleman, J. P., van der Lei, J., ‘t Jong, G. W., Kingma, J. H., Sturkenboom, M. C. J. M., & Stricker, B. H. C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1293 · Cited by 260 · cited 1×
“Concerns about QT prolongation, torsades de pointes [45], and other arrhythmogenic effects have led to more cautious dosing and greater preference for SGAs and monotherapy when possible [46–48].”
Oxidative Stress‐Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Ermakov, E. A., Dmitrieva, E. M., Parshukova, D. A., Kazantseva, D. V., Vasilieva, A. R., & Smirnova, L. P. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8881770 · Cited by 233
Sudden death in psychiatric patients
Ruschena, D., Mullen, P. E., Burgess, P., Cordner, S., Barry-Walsh, J., Drummer, O., Palmer, S., Browne, C., & Wallace, C. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.4.331 · Cited by 217 · cited 1×
“Sudden unexpected death was defined as a rapid, unforeseen fatal event occurring in an otherwise stable inpatient or within one hour of new symptom onset, consistent with definitions used in psychiatric settings [6,41].”
The genetics underlying acquired long QT syndrome: impact for genetic screening
Itoh, H., Crotti, L., Aiba, T., Spazzolini, C., Denjoy, I., Fressart, V., Hayashi, K., Nakajima, T., Ohno, S., Makiyama, T., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv695 · Cited by 215 · cited 1×
“Moreover, Itoh et al. (2016) [34] demonstrated that nearly one-third of patients with acquired long QT syndrome carry mutations in congenital LQTS genes, suggesting that latent genetic variants may predispose to drug-induced arrhythmias.”
Metadata
- Authors
- Popa, A.-V., Ifteni, P. I., Petric, P. S., Țâbian, D., & Teodorescu, A.
- Affiliations
- Transilvania University of Brașov (RO)
- Corresponding author
- Ifteni, Petru Iulian
- Venue
- Medicina
- Publisher
- MDPI AG
- Published
- 2025-11-22
- Volume
- 61
- Issue
- 12
- Pages
- 2081
- ISSN
- 1010-660X (ISSN-L)
- 1648-9144
- PMC
- PMC12734535
- OpenAlex
- W4416571710
- Cited by
- 0
- References
- 61
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Medicina (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- sudden unexpected death, schizophrenia, hospitalized patients, atypical antipsychotics, cardiovascular comorbidity, airway obstruction, incidence trends, autopsy findings, forensic medicine, life expectancy
- MeSH terms
- Adult, Aged, Cause of Death, Death, Sudden, Female, Humans, Inpatients, Male, Middle Aged, Retrospective Studies, Schizophrenia, Antipsychotic Agents, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends in Sudden Death Among Schizophrenia Inpatients. https://app.cochat.ai/papers/10.3390/medicina61122081
- The paper
- Popa, A.-V., Ifteni, P. I., Petric, P. S., Țâbian, D., & Teodorescu, A. (2025). Trends in Sudden Death Among Schizophrenia Inpatients. Medicina. https://doi.org/10.3390/medicina61122081
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.